Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-03

FDA Approved: AUSTEDO — Original Application (Teva Neuroscience, Inc.)

View source ↗

Summary

FDA approved AUSTEDO (deutetrabenazine) in an original application for the treatment of chorea in Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUSTEDO (deutetrabenazine)

Snippet

ORIG AP for AUSTEDO (DEUTETRABENAZINE)